New PCT patent applications published

Two new PCT patent applications relevant to the Australian and New Zealand Life Sciences sector published this week:

• WO/2016/161477, from Prince Henry's Institute of Medical Research in Melbourne, has been published for A method of treating neoplasias. This application covers the combination of antagonists to GDF-11, a myostatin-homologous protein, and activin A, a member of the transforming growth factor-beta superfamily, in sensitising tumours to chemotherapy.
  
• WO/2016/163894, from the Christchurch-based Cropmark Seeds, has been published for Control of parasitic infection in animals. This application covers grasses that have been infected with endophytes where the grass contains loline alkaloids, useful in treating internal infection by parasites in sheep.
  

To look at Life Science PCT patent applications by Australian and New Zealand applicants since the beginning of 2014 click here.